# OnCo record dipss-mipss70 (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/dipss-mipss70/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "dipss-mipss70" ;
  schema:name "DIPSS, DIPSS-plus and MIPSS70 (myelofibrosis risk scores)"@en ;
  schema:alternateName "DIPSS"@en, "DIPSS-plus"@en, "IPSS for myelofibrosis"@en, "MIPSS70"@en, "MIPSS70-plus"@en, "MIPSS70+ v2"@en, "MIPSS70-plus version 2"@en, "GIPSS"@en, "MYSEC-PM"@en, "high-molecular-risk mutations"@en, "HMR mutations"@en, "myelofibrosis risk score"@en, "intermediate-2 myelofibrosis"@en, "high-risk myelofibrosis"@en ;
  schema:description "Myelofibrosis risk scores decide the biggest question in the disease, whether to go for a stem-cell transplant: DIPSS uses age, blood counts, blasts and symptoms, DIPSS-plus adds chromosomes, transfusions and platelets, and MIPSS70 adds the mutations that mark a dangerous clone."@en ;
  schema:url <https://onco.cc/terms/dipss-mipss70/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:related <https://onco.cc/terms/mpn-driver-mutations/>, <https://onco.cc/terms/cytogenetics/>, <https://onco.cc/terms/blasts/>, <https://onco.cc/terms/performance-status/>, <https://onco.cc/terms/allogeneic-transplant/>, <https://onco.cc/drugs/ruxolitinib/>, <https://onco.cc/drugs/fedratinib/>, <https://onco.cc/drugs/pacritinib/>, <https://onco.cc/drugs/momelotinib/> ;
  onco:cancers <https://onco.cc/cancers/primary-myelofibrosis/> .
